Vanguard Group’s Viracta Therapeutics, Inc. Common Stock VIRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q1
Sell
-289,174
Closed -$46.6K 4339
2024
Q4
$46.6K Sell
289,174
-665,311
-70% -$107K ﹤0.01% 4219
2024
Q3
$220K Sell
954,485
-206,795
-18% -$47.8K ﹤0.01% 4122
2024
Q2
$631K Hold
1,161,280
﹤0.01% 3930
2024
Q1
$1.18M Hold
1,161,280
﹤0.01% 3757
2023
Q4
$662K Buy
1,161,280
+13,368
+1% +$7.62K ﹤0.01% 3955
2023
Q3
$1.19M Hold
1,147,912
﹤0.01% 3765
2023
Q2
$1.62M Hold
1,147,912
﹤0.01% 3732
2023
Q1
$1.83M Hold
1,147,912
﹤0.01% 3711
2022
Q4
$1.68M Buy
1,147,912
+33,544
+3% +$49K ﹤0.01% 3728
2022
Q3
$4.76M Buy
1,114,368
+207,108
+23% +$884K ﹤0.01% 3357
2022
Q2
$3.52M Buy
907,260
+78,383
+9% +$304K ﹤0.01% 3550
2022
Q1
$3.95M Sell
828,877
-625,449
-43% -$2.98M ﹤0.01% 3641
2021
Q4
$5.31M Buy
1,454,326
+9,711
+0.7% +$35.4K ﹤0.01% 3573
2021
Q3
$11.6M Buy
1,444,615
+10,693
+0.7% +$85.8K ﹤0.01% 3155
2021
Q2
$16.3M Buy
1,433,922
+1,225,874
+589% +$13.9M ﹤0.01% 2938
2021
Q1
$1.92M Buy
208,048
+111,611
+116% +$1.03M ﹤0.01% 3869
2020
Q4
$671K Buy
96,437
+9,117
+10% +$63.4K ﹤0.01% 3909
2020
Q3
$382K Sell
87,320
-33,047
-27% -$145K ﹤0.01% 3852
2020
Q2
$1.11M Sell
120,367
-1,625
-1% -$15K ﹤0.01% 3587
2020
Q1
$1.77M Buy
121,992
+3,931
+3% +$57.1K ﹤0.01% 3342
2019
Q4
$1.4M Hold
118,061
﹤0.01% 3545
2019
Q3
$2.98M Buy
118,061
+52,821
+81% +$1.33M ﹤0.01% 3310
2019
Q2
$1.66M Buy
65,240
+45,348
+228% +$1.15M ﹤0.01% 3523
2019
Q1
$846K Buy
19,892
+7,999
+67% +$340K ﹤0.01% 3670
2018
Q4
$173K Sell
11,893
-19,647
-62% -$286K ﹤0.01% 3926
2018
Q3
$2.21M Sell
31,540
-435
-1% -$30.5K ﹤0.01% 3495
2018
Q2
$2.37M Sell
31,975
-1,351
-4% -$100K ﹤0.01% 3448
2018
Q1
$3.17M Buy
33,326
+4,383
+15% +$417K ﹤0.01% 3306
2017
Q4
$3.74M Buy
28,943
+11,705
+68% +$1.51M ﹤0.01% 3244
2017
Q3
$1.17M Sell
17,238
-69
-0.4% -$4.68K ﹤0.01% 3550
2017
Q2
$1.64M Buy
17,307
+680
+4% +$64.2K ﹤0.01% 3442
2017
Q1
$2.39M Buy
16,627
+4,314
+35% +$619K ﹤0.01% 3327
2016
Q4
$1.56M Buy
12,313
+1,124
+10% +$142K ﹤0.01% 3446
2016
Q3
$1.71M Sell
11,189
-714
-6% -$109K ﹤0.01% 3437
2016
Q2
$1.37M Buy
11,903
+101
+0.9% +$11.6K ﹤0.01% 3514
2016
Q1
$1.34M Buy
11,802
+1,600
+16% +$182K ﹤0.01% 3508
2015
Q4
$1.92M Buy
10,202
+612
+6% +$115K ﹤0.01% 3409
2015
Q3
$1.63M Buy
9,590
+1,379
+17% +$235K ﹤0.01% 3464
2015
Q2
$5.19M Buy
8,211
+24
+0.3% +$15.2K ﹤0.01% 3001
2015
Q1
$4.21M Buy
8,187
+513
+7% +$264K ﹤0.01% 3077
2014
Q4
$4.11M Buy
7,674
+736
+11% +$394K ﹤0.01% 2998
2014
Q3
$10.4M Buy
6,938
+631
+10% +$946K ﹤0.01% 2472
2014
Q2
$8.64M Buy
6,307
+310
+5% +$424K ﹤0.01% 2567
2014
Q1
$8.33M Buy
5,997
+917
+18% +$1.27M ﹤0.01% 2574
2013
Q4
$5.06M Buy
5,080
+536
+12% +$534K ﹤0.01% 2797
2013
Q3
$4.73M Buy
4,544
+11
+0.2% +$11.5K ﹤0.01% 2775
2013
Q2
$4.96M Buy
+4,533
New +$4.96M ﹤0.01% 2669